Cargando…
The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression
Breast cancer is one of the most common malignancies worldwide, while the luminal types (ERα positive) accounts for two third of all breast cancer cases. Although ERα positive breast cancer could be effective controlled by endocrine therapy, most of the patients will develop endocrine resistance, wh...
Autores principales: | Niu, Zhiguo, Li, Xin, Feng, Suyin, Huang, Qingsong, Zhuang, Ting, Yan, Cheng, Qian, Hui, Ding, Yinlu, Zhu, Jian, Xu, Wenrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591989/ https://www.ncbi.nlm.nih.gov/pubmed/33123289 http://dx.doi.org/10.7150/jca.50477 |
Ejemplares similares
-
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
por: Xia, Xiaohong, et al.
Publicado: (2021) -
USP21 modulates Goosecoid function through deubiquitination
por: Liu, Fuwei, et al.
Publicado: (2019) -
The E3 Ubiquitin Ligase HOIP inhibits Cancer Cell Apoptosis via modulating PTEN stability
por: Niu, Zhiguo, et al.
Publicado: (2021) -
The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression
por: Zhu, Jian, et al.
Publicado: (2020) -
Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11
por: Vlasschaert, Caitlyn, et al.
Publicado: (2015)